Peter H. Kamper

Palle Juul Jensens Boulevard 99
Arhus, 8200, Denmark

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications

Long-Term Quality of Life in 1777 Persons With Hodgkin Lymphoma and 6166 Matched Comparators.

Long-Term Quality of Life in 1777 Persons With Hodgkin Lymphoma and 6166 Matched Comparators.

Journal: American journal of hematology
Published: January 14, 2026

Validation of the newly introduced Deauville Score 5a in patients treated for advanced-stage classic Hodgkin Lymphoma.

Validation of the newly introduced Deauville Score 5a in patients treated for advanced-stage classic Hodgkin Lymphoma.

Journal: Blood advances
Published: January 13, 2026

AVD is an effective chemotherapy backbone in first-line treatment of older patients with classical Hodgkin lymphoma.

AVD is an effective chemotherapy backbone in first-line treatment of older patients with classical Hodgkin lymphoma.

Journal: Blood advances
Published: October 31, 2025

Paraneoplastic Neuro-Ophthalmologic Symptoms as Initial Manifestation of Hodgkin Lymphoma.

Paraneoplastic Neuro-Ophthalmologic Symptoms as Initial Manifestation of Hodgkin Lymphoma.

Journal: Hematology reports
Published: October 28, 2025

Lymph node transcriptomic profiles suggest susceptibility to bleomycin-induced pulmonary toxicity in classic hodgkin lymphoma.

Lymph node transcriptomic profiles suggest susceptibility to bleomycin-induced pulmonary toxicity in classic hodgkin lymphoma.

Journal: Scientific reports
Published: April 28, 2025

Epidemiological evidence for the role of puberty and immune senescence in Hodgkin lymphoma aetiology from 1992 Danish cases.

Epidemiological evidence for the role of puberty and immune senescence in Hodgkin lymphoma aetiology from 1992 Danish cases.

Journal: International journal of cancer
Published: April 15, 2025

Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients.

Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients.

Journal: HemaSphere
Published: April 14, 2025

Tumor-associated macrophages: potential role in skeletal involvement in classic Hodgkin lymphoma.

Tumor-associated macrophages: potential role in skeletal involvement in classic Hodgkin lymphoma.

Journal: The journal of pathology. Clinical research
Published: March 27, 2025

Proteomic profiling identifies classic Hodgkin lymphoma patients at risk of bleomycin pulmonary toxicity.

Proteomic profiling identifies classic Hodgkin lymphoma patients at risk of bleomycin pulmonary toxicity.

Journal: Leukemia & lymphoma
Published: December 03, 2024

Brentuximab vedotin monotherapy is a feasible and effective treatment for older patients with classical Hodgkin lymphoma unsuitable for curative chemotherapy: Results from the prospective GHSG-NLG phase II BVB trial.

Brentuximab vedotin monotherapy is a feasible and effective treatment for older patients with classical Hodgkin lymphoma unsuitable for curative chemotherapy: Results from the prospective GHSG-NLG phase II BVB trial.

Journal: HemaSphere
Published: November 12, 2024

Fertility in patients with advanced-stage classic Hodgkin lymphoma treated with BrECADD versus eBEACOPP: a secondary analysis of the multicentre, randomised, parallel, open-label, phase 3 HD21 trial.

Fertility in patients with advanced-stage classic Hodgkin lymphoma treated with BrECADD versus eBEACOPP: a secondary analysis of the multicentre, randomised, parallel, open-label, phase 3 HD21 trial.

Journal: The Lancet. Oncology
Published: November 08, 2024

Risk of Cardiovascular Disease in Patients With Classical Hodgkin Lymphoma: A Danish Nationwide Register-Based Cohort Study.

Risk of Cardiovascular Disease in Patients With Classical Hodgkin Lymphoma: A Danish Nationwide Register-Based Cohort Study.

Journal: European journal of haematology
Published: July 11, 2024
Showing 1-12 of 44

Last Updated: 09/26/2026